Advertisement

Drugs & Therapy Perspectives

, Volume 14, Issue 3, pp 9–11 | Cite as

Increased support for β-blocker use in patients with heart failure

New Drugs and Disease Management
  • 9 Downloads

Keywords

Heart Failure Chronic Heart Failure Metoprolol Carvedilol Bisoprolol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997 May; 18: 736–53CrossRefGoogle Scholar
  2. 2.
    Consensus recommendations for the treatment of patients with heart failure. Am J Cardiol 1999 Jan 21; 83 Suppl. 2A: 1A–38AGoogle Scholar
  3. 3.
    Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441–6PubMedCrossRefGoogle Scholar
  4. 4.
    White M, Rouleau J-L, Pericak D, et al. Effects of metoprolol-CR in patients with ischaemic and dilated cardiomyopathy: the RESOLVD pilot study (phase II) [abstract]. Eur Heart J 1998; 19 (Suppl.): 308CrossRefGoogle Scholar
  5. 5.
    Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). Lancet 1999 Jun 12; 353: 2001–7Google Scholar
  6. 6.
    CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765–73CrossRefGoogle Scholar
  7. 7.
    CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 Jan 2; 353: 9–13CrossRefGoogle Scholar
  8. 8.
    Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996; 94: 2800–6PubMedCrossRefGoogle Scholar
  9. 9.
    Australian/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 349: 375–80CrossRefGoogle Scholar
  10. 10.
    Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of Carvedilol in patients with moderate to severe heart failure. Circulation 1996; 94: 2793–9PubMedCrossRefGoogle Scholar
  11. 11.
    Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996; 94: 2807–16PubMedCrossRefGoogle Scholar
  12. 12.
    Cohn JN, Fowler MB, Bristow MR, et al. Safety and efficacy of carvedilol in severe heart failure. J Card Failure 1997; 3: 173–9CrossRefGoogle Scholar
  13. 13.
    Cleland JGF, McGowan J, Clark A. The evidence for beta blockers in heart failure: equals or surpasses that for angiotensin converting enzyme inhibitors. BMJ 1999 Mar 27; 318: 824PubMedCrossRefGoogle Scholar
  14. 14.
    Packer M, Bristow MR, Cohn JN, et al. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Eng J Med 1996 May 23; 334: 1349–55CrossRefGoogle Scholar
  15. 15.
    Hjalmarson Å, Kneider M, Waagstein F. The role of β-blockers in left ventricular dysfunction and heart failure. Drugs 1997 Oct; 54(4): 501–10PubMedCrossRefGoogle Scholar
  16. 16.
    New consensus report urges four-drug regimen for stable heart failure patients. Formulary 1999 Mar; 34: 202Google Scholar
  17. 17.
    Carvedilol more than an antihypertensive: new data show efficacy in CHF and MI. Drug Ther Perspect 1997 Nov 10; 10(10): 1–5Google Scholar
  18. 18.
    Lindsay J, Freemantie N, Nazareth I. β-blockers in heart failure. Lancet 1999 Mar 20; 353: 1011PubMedCrossRefGoogle Scholar
  19. 19.
    Avezum Á, Tsuyuki RT, Pogue J, et al. Beta-blocker therapy for congestive heart failure: a systematic overview and critical appraisal of the published trials. Can J Cardiol 1998 Aug; 14(8): 1045–53PubMedGoogle Scholar
  20. 20.
    Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996; 94: 2807–16PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Personalised recommendations